Proton Pump Inhibitors: all 885 studies that test it
Page 9 of 9. Open to participants first (51), then studies with results posted, then the rest; newest registration first within each.
- Study of Proton Pump Inhibitors (PPI) to Prevent Strictures After Gastric Bypass SurgeryWithdrawnNCT00361985Phase 4
- Drug Interaction Study With Proton Pump InhibitorCompletedNCT00357240Phase 1
- CYP2C19 Genetic Polymorphism on the Accuracy of Proton-Pump Inhibitor TestingCompletedNCT00354757Phase 4
- An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus PatientsCompletedNCT00352261Phase 4
- Symptom Adapted Therapy in GERD PatientsCompletedNCT00343161Phase 4
- A Randomized Multi-Intervention Trial to Inhibit Precancerous Gastric Lesions in Lingu, Shandong ProvinceCompletedNCT00339768Phase 3
- Symptom Assessment in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) or enGERD (Endoscopic-negative GERD) After Treatment With Pantoprazole (BY1023/M3-343)CompletedNCT00336219Phase 3
- Prospective Study of First-line Antibiotic Therapy for Early-stage Gastric MALT Lymphoma for Treatment OutcomeCompletedNCT00327132Not applicable
- Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Non-erosive Reflux or Gastroesophageal Reflux Disease (BY1023/DE-004)CompletedNCT00326027Phase 3
- Comparison of the Classical Healing Concept With the Complete Remission Concept After Treatment With Pantoprazole in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) (BY1023/M3-342)CompletedNCT00325676Phase 4
- Nexium RESPONSE TrialCompletedNCT00318968Phase 4
- PPI Test in GP PatientsCompletedNCT00318084Phase 4
- Effect of Pantoprazole on the Symptoms of Acid Reflux Disease in Adult Patients (BY1023/M3-341)CompletedNCT00312806Phase 3
- Study of Pantoprazole for Sleepiness Associated With Acid Reflux and Sleep ApneaCompletedNCT00307944Phase 4
- Comparison of the Nighttime Effects of Two Different Drugs on Subjects With GERDCompletedNCT00304421Phase 4
- Randomized Trial for Pharmacogenomics-based Proton Pump Inhibitor Therapy in ChildrenWithdrawnNCT00299845Phase 4
- Validation of RDQ QuestionnaireCompletedNCT00291746Phase 4
- Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis PatientsCompletedNCT00290823Phase 3
- Sleep Disorders and Gastroesophageal Reflux Disease (GERD)CompletedNCT00287391Phase 4
- Effects of 2 Different Doses of Pantoprazole on Gastric pH and Recurrent Bleeding in Patients Who Bled From Peptic UlcersCompletedNCT00279123Phase 4
- Prevacid vs Lifestyle Modifications for the Treatment of LPRStatus unknownNCT00274339Not applicable
- Esomeprazole in PPI Failures - IMPROVECompletedNCT00272701Phase 4
- Determination of a Questionnaire After Treatment With Pantoprazole at Full Dose and Half Dose in Adult Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/UK-506)CompletedNCT00261339Phase 4
- Long-term Pantoprazole Trial in Patients With Symptoms of Chronic Acid Peptic Complaints (BY1023/VMG-708)CompletedNCT00261300Phase 3
- Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese PopulationCompletedNCT00259077Phase 3
- A Study to Investigate the Pharmacodynamic Effect After Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese PopulationCompletedNCT00259051Phase 3
- Sopran - Omeprazole Treatment Versus SurgeryCompletedNCT00256737Phase 3
- Nexium Dyspepsia/ASTCompletedNCT00251992Phase 3
- ASTERIX: Low Dose ASA and NexiumCompletedNCT00251966Phase 3
- Nexium Dyspepsia/ASTCompletedNCT00251914Phase 3
- Chest Pain Pilot StudyCompletedNCT00251901Phase 3
- Comparison of a "Step-Up" Versus a "Step-Down" Treatment Strategy for Patients With New Onset Dyspepsia in General Practice (The DIAMOND-Study)CompletedNCT00247715Not applicable
- Comparison of Intravenous Omeprazole to Ranitidine on Recurrent Bleeding After Endoscopic Treatment of Bleeding UlcerWithdrawnNCT00247130Phase 4
- Determination of the Minimal Clinically Important Difference After Treatment With Pantoprazole in Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-340)CompletedNCT00246909Phase 4
- HEARD (Long Term) Study - Histology of the Esophagus in Acid-Related DiseaseCompletedNCT00243724Phase 3
- An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD)CompletedNCT00242736Phase 4
- Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDsCompletedNCT00241553Phase 3
- Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDsCompletedNCT00241540Phase 3
- Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDsCompletedNCT00241527Phase 3
- Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDsCompletedNCT00241514Phase 3
- Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent PatientsCompletedNCT00241501Phase 3
- Effect of Prevacid on Prostaglandin Levels in Patient With Stress UlcerCompletedNCT00239551Phase 4
- A Study of Rabeprazole and Pantoprazole on Stomach Acid and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (GERD) and a History of Nighttime HeartburnCompletedNCT00237367Phase 4
- A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy.Status unknownNCT00237068Phase 4
- A Study of Efficacy and Safety of "On-demand" Maintenance Therapy With Rabeprazole in Patients With Non-erosive Reflux Disease (NERD)CompletedNCT00236392Phase 3
- Improvement in Bronchial Asthma in Patients With Extraesophageal Reflux After Acid SuppressionCompletedNCT00234117Not applicable
- Esomeprazole for Treatment of GERD in Pediatric PatientsCompletedNCT00228527Phase 4
- The Effects of Nexium on the Side Effects Associated With a Colonoscopy PrepCompletedNCT00225238Phase 4
- PPI Versus Placebo in Severe Functional HeartburnWithdrawnNCT00222989Not applicable
- Rabeprazole in Subjects With Gastroesophageal Reflux Disease (GERD)CompletedNCT00222170Phase 2
- Evaluation of Esomeprazole in Treating Gastro-esophageal Reflux Disease (GERD) in Head and Neck Cancer Patients Exposed to Radiation TherapyTerminatedNCT00222079Not applicable
- Lansoprazole Preventing Gastroduodenal Stress UlcerationsTerminatedNCT00220909Phase 4
- Rabeprazole Protection of Aspirin Induced Gastric Damage.CompletedNCT00220857Phase 4
- A Study to Evaluate the Effect of Lansoprazole on Infants With Gastroesophageal Reflux Disease.CompletedNCT00220818Phase 1
- The Effect of Nexium on Transmucosal Esophageal LeakStatus unknownNCT00216788Phase 1
- A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD)CompletedNCT00216489Phase 4
- Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults.CompletedNCT00216450Phase 4
- Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma.CompletedNCT00214552Phase 3
- NEXIUM® in the Treatment of Moderate and Severe Erosive EsophagitisCompletedNCT00206180Phase 4
- Study of Intragastric pH Profile After 5 Days Pantoprazole 40 mg iv Followed by Oral Esomeprazole 40 mg po or Oral Pantoprazole 40 mg poCompletedNCT00206050Phase 4
- Acid-Associated Heartburn Symptoms and Dose of EsomeprazoleCompletedNCT00206024Phase 4
- Laryngopharyngeal Reflux and Proton Pump Inhibitor (PPI) TreatmentCompletedNCT00204698Phase 2/3
- Post-nasal Drainage as an Extraesophageal Manifestation of RefluxCompletedNCT00199953Phase 2
- Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) InfectionStatus unknownNCT00197418Phase 2/3
- A Randomized Controlled Trial of Laparoscopic Nissen Fundoplication Treatment of Patients With Chronic GERDCompletedNCT00182260Not applicable
- Intravenous vs Oral Lansoprazole on Gastric Acid Secretion in Subjects With Erosive EsophagitisCompletedNCT00175045Phase 2
- A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose AspirinCompletedNCT00175032Phase 3
- A Study to Evaluate the Effect of Lansoprazole on Hospitalized Neonates With Gastroesophageal Reflux DiseaseCompletedNCT00174928Phase 1
- A Study Comparing High Dose Omeprazole Infusion Against Scheduled Second Endoscopy for Bleeding Peptic UlcerCompletedNCT00164931Phase 3
- Administration of High-Dose Intravenous Proton Pump Inhibitor for Upper Gastrointestinal Bleeding Prior to EndoscopyCompletedNCT00164866Phase 4
- Symptomatic Gastroesophageal Reflux Disease: Double Blind Randomized Controlled Study of On-demand Therapy Versus Maintenance TherapyCompletedNCT00164840Phase 3
- A Comparison of Gastric pH Control With High Dose Intravenous or Oral EsomeprazoleTerminatedNCT00164788Phase 2
- Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-339)CompletedNCT00163306Phase 3
- Esophageal Metaplasia Using a Novel Antibody: Reversibility by Proton Pump InhibitorTerminatedNCT00161200Phase 3
- On-Demand Use of Pantoprazole: Determinants for Chronic Use of Acid Suppressive MedicationStatus unknownNCT00161096Phase 3
- Intravenous Pantoloc In Aspirin-Induced Ulcer BleedingCompletedNCT00153725Not applicable
- Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. PyloriStatus unknownNCT00149084Phase 3
- Intravenous (IV) Pantoprazole in Erosive EsophagitisCompletedNCT00133770Phase 4
- Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic EsophagitisCompletedNCT00123656Phase 2
- Proton Pump Inhibitor Treatment StopCompletedNCT00120315Phase 4
- Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison SyndromeCompletedNCT00079833Phase 3
- Study Evaluating Pantoprazole in Peptic Ulcer HemorrhageCompletedNCT00040495Phase 3
- Study Evaluating Pantoprazole in Peptic Ulcer HemorrhageCompletedNCT00037570Phase 2
- Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the StomachCompletedNCT00002682Phase 2
- The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric AcidCompletedNCT00001191Phase 2